Un estudio liderado desde el Centro de Biología Molecular Severo Ochoa, centro mixto del Consejo Superior de Investigaciones Científicas (CSIC) y la Universidad Autónoma de Madrid (UAM), y en colab...
Read moreThe research also opens the door to new neurotransmitter modulating drugs that could be effective treatments
Read moreResearchers at IBEC manage to recreate the complex composition of human breast tumors in the laboratory using tissues from female pig breasts. This new model will allow, among other applications, the ...
Read moreThe study, led by researchers from Hospital Clínic-IDIBAPS, analyzes the genetic variants associated with the risk of developing the cancer and should make it possible to reduce the number of unneces...
Read moreAn international study involving the IBB-UAB has identified how the 20 different forms of the p53 protein, unique to elephants, are activated to increase sensitivity and response against carcinogenic ...
Read moreLa combinación de inteligencia artificial y tecnologías de aprendizaje automático permite augurar un futuro con diagnósticos más fiables y personalizados para tratar con mayor eficacia enfermedad...
Read moreFoundation for Addie’s Research Joins Oncoheroes moving volasertib into a clinical trial to create more and better options for children fighting cancer.
Read moreVall d’Hebron Research Institute (VHIR), a world-leading healthcare institution where healthcare, research, innovation and education go hand in hand, and Oncoheroes Biosciences, a biotech company ex...
Read moreLa nueva tecnología adquirida por el Hospital Universitario Vall d’Hebron gracias a los fondos FEDER se aplicará a la mayor parte de diagnósticos de infección bacteriana, tanto de pacientes ingr...
Read moreUn equipo de investigación de la Universidad de Almería ha colaborado en la evaluación de los beneficios de la ingesta de antioxidantes y ácidos grasos procedentes de los residuos orgánicos gener...
Read moreInbiomotion SL, a company developing a unique single-gene-based biomarker for the personalized adjuvant treatment of early-stage (stage I-III) breast cancer patients, announces the results of comparin...
Read moreUna colaboración internacional liderada por investigadoras del IIB Sant Pau, el CIBERCV, el IIBB-CSIC e instituciones científicas de Argentina demuestra que la inmunoterapia dirigida al receptor LRP...
Read more